The survival period of lupus nephritis is related to the condition and the treatment effect and cannot be generalized. If the condition is mild and the treatment effect is good, it may not affect the survival period of the patient; if the condition is severe and the treatment effect is poor, it may shorten the survival period of the patient as the condition progresses and develops into uremia. Lupus nephritis is the kidney damage of SLE. More than 50% of SLE patients have kidney damage, and kidney biopsy shows almost 100% kidney involvement. Lupus nephritis is one of the major causes of end-stage renal failure in this country. If the condition is relatively mild and is treated aggressively and effectively, it may not affect the survival period of the patient; if the condition is more severe and the treatment is ineffective, it may shorten the survival period of the patient as the condition progresses and eventually develops into uremia. The exact survival time cannot be determined. Lupus nephritis can be in long-term remission after treatment, but it is easy to relapse after the drug is reduced or discontinued, and the condition gradually worsens. In recent years, due to the improvement of lupus nephritis diagnosis, early detection of mild cases and rational application of immunosuppressants, the prognosis has been significantly improved, and the 10-year survival rate has been increased to 80%~90%. If patients find lupus nephritis, it is recommended to go to regular hospitals in time and receive standardized treatment under the guidance of doctors.